Back

Myeloperoxidase as therapeutic target in HFpEF

27 August 2022 (14:15 - 14:45)
Organised by:
Congress Presentation Part of: Chronic heart failure - New treatments and trials Pathophysiology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Sibille Lejeune

Cliniques Saint-Luc UCL, Brussels (Belgium)

4 More presentations in this session

Presentation thumbnail
The I4RON-HF study, Intravenous Iron Isomaltoside for Inpatients veRsus Outpatient Asians with Heart Failure
Doctor T. Lee (Kuala Lumpur, MY)
Abstract Slides
Presentation thumbnail
The effects of combined hyperbaric oxygenation and erythropoietin therapy in treatment of heart failure
Professor P. Mitrovic (Belgrade, RS)
Slides
Presentation thumbnail
First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function
Doctor H. Bahrami (Herlev, DK)
Abstract Slides
Presentation thumbnail
Chronic mitochondrial fusion promotor as a novel pharmacological intervention to alleviate left ventricular dysfunction in rats with chronic myocardial infarction
Doctor C. Maneechote (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - New treatments and trials

The Event

Event poster

ESC Congress 2022

27 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Presentation
From hypertension to heart failure: pathophysiology
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Chronic kidney disease and heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources